Literature DB >> 19469002

Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis.

Walkíria Wingester Vilas-Boas1, Antônio Ribeiro-Oliveira, Regina Maria Pereira, Renata da Cunha Ribeiro, Jerusa Almeida, Ana Paula Nadu, Ana Cristina Simões e Silva, Robson Augusto Souza dos Santos.   

Abstract

AIM: To measure circulating angiotensins at different stages of human cirrhosis and to further evaluate a possible relationship between renin angiotensin system (RAS) components and hemodynamic changes.
METHODS: Patients were allocated into 4 groups: mild-to-moderate liver disease (MLD), advanced liver disease (ALD), patients undergoing liver transplantation, and healthy controls. Blood was collected to determine plasma renin activity (PRA), angiotensin (Ang) I, Ang II, and Ang-(1-7) levels using radioimmunoassays. During liver transplantation, hemodynamic parameters were determined and blood was simultaneously obtained from the portal vein and radial artery in order to measure RAS components.
RESULTS: PRA and angiotensins were elevated in ALD when compared to MLD and controls (P < 0.05). In contrast, Ang II was significantly reduced in MLD. Ang-(1-7)/Ang II ratios were increased in MLD when compared to controls and ALD. During transplantation, Ang II levels were lower and Ang-(1-7)/Ang II ratios were higher in the splanchnic circulation than in the peripheral circulation (0.52 +/- 0.08 vs 0.38 +/- 0.04, P < 0.02), whereas the peripheral circulating Ang II/Ang I ratio was elevated in comparison to splanchnic levels (0.18 +/- 0.02 vs 0.13 +/- 0.02, P < 0.04). Ang-(1-7)/Ang II ratios positively correlated with cardiac output (r = 0.66) and negatively correlated with systemic vascular resistance (r = -0.70).
CONCLUSION: Our findings suggest that the relationship between Ang-(1-7) and Ang II may play a role in the hemodynamic changes of human cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19469002      PMCID: PMC2686910          DOI: 10.3748/wjg.15.2512

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Plasma concentrations of angiotensin metabolites in young male normotensive and mild hypertensive subjects.

Authors:  T Matsui; K Tamaya; K Matsumoto; Y Osajima; K Uezono; T Kawasaki
Journal:  Hypertens Res       Date:  1999-11       Impact factor: 3.872

Review 2.  Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

Authors:  Vicente Arroyo; Jordi Colmenero
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

3.  Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats.

Authors:  Walkyria O Sampaio; Antonio A S Nascimento; Robson A S Santos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-02-06       Impact factor: 4.733

4.  Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.

Authors:  A Helmy; R Jalan; D E Newby; P C Hayes; D J Webb
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

Review 5.  Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.

Authors:  Vicente Arroyo; Carlos Terra; Pere Ginès
Journal:  J Hepatol       Date:  2007-02-27       Impact factor: 25.083

Review 6.  The hyperdynamic circulation in cirrhosis: an overview.

Authors:  L Blendis; F Wong
Journal:  Pharmacol Ther       Date:  2001-03       Impact factor: 12.310

7.  Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients.

Authors:  Walkíria Wingester Vilas-Boas; Antônio Ribeiro-Oliveira; Renata da Cunha Ribeiro; Renata Lúcia Pereira Vieira; Jerusa Almeida; Ana Paula Nadu; Ana Cristina Simões e Silva; Robson Augusto Souza Santos
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

8.  Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

Authors:  Ramón Bataller; Pau Sancho-Bru; Pere Ginès; José M Lora; Amal Al-Garawi; Manel Solé; Jordi Colmenero; Josep M Nicolás; Wladimiro Jiménez; Nadine Weich; José-Carlos Gutiérrez-Ramos; Vicente Arroyo; Juan Rodés
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

Review 9.  Vascular endothelial dysfunction in cirrhosis.

Authors:  Yasuko Iwakiri; Roberto J Groszmann
Journal:  J Hepatol       Date:  2007-03-05       Impact factor: 25.083

10.  Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis.

Authors:  Chandana B Herath; Fiona J Warner; John S Lubel; Rachael G Dean; Zhiyuan Jia; Rebecca A Lew; A Ian Smith; Louise M Burrell; Peter W Angus
Journal:  J Hepatol       Date:  2007-04-02       Impact factor: 25.083

View more
  13 in total

Review 1.  Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.

Authors:  Ahmed A Magan; Atif A Khalil; Mohamed H Ahmed
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 2.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 3.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

Review 5.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

Review 6.  Renin angiotensin system in liver diseases: Friend or foe?

Authors:  Ana Cristina Simões E Silva; Aline S Miranda; Natália P Rocha; Antônio L Teixeira
Journal:  World J Gastroenterol       Date:  2017-05-21       Impact factor: 5.742

7.  Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats.

Authors:  Lakmie S Gunarathne; Peter W Angus; Chandana B Herath
Journal:  Front Physiol       Date:  2019-09-20       Impact factor: 4.566

Review 8.  Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.

Authors:  Yannis Dimitroglou; Constantina Aggeli; Alexandra Alexopoulou; Sophie Mavrogeni; Dimitris Tousoulis
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

9.  Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis.

Authors:  Qianqian Zhu; Na Li; Fang Li; Zhihua Zhou; Qunying Han; Yi Lv; Jiao Sang; Zhengwen Liu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-03-23       Impact factor: 1.636

Review 10.  Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.

Authors:  Lakmie S Gunarathne; Harinda Rajapaksha; Nicholas Shackel; Peter W Angus; Chandana B Herath
Journal:  World J Gastroenterol       Date:  2020-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.